Condition (MeSH)
Postgastrectomy Syndromes
ClinicalTrials.gov lists 21 trials for Postgastrectomy Syndromes or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 21 trials are tagged with Postgastrectomy Syndromes itself; the rest are tagged with a narrower condition beneath it.
When did Postgastrectomy Syndromes trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 3 |
| 2022 | 1 |
| 2021 | 2 |
| 2020 | 1 |
| 2017 | 4 |
| 2016 | 1 |
| 2013 | 2 |
| 2011 | 1 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Postgastrectomy Syndromes trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 3 |
| Not applicable | 11 |
| Observational | 3 |
How many Postgastrectomy Syndromes trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Completed | 11 |
| Terminated | 1 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Postgastrectomy Syndromes trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Instituto Mexicano del Seguro Social | 1 |
| Novartis Pharmaceuticals | 1 |
| RECORDATI GROUP | 1 |
Which drugs are being tested for Postgastrectomy Syndromes? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Sulfasalazine | 1 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Pasireotide s.c. | 3 |
| Empagliflozine | 1 |
| Cabergoline Pill | 1 |
| Rifaximine | 1 |
| LAR Octreotide | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Postgastrectomy Syndromes trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cholelithiasis | 9 | 1 |
| COVID-19 | 8 | 1 |
| Cholecystitis | 5 | 1 |
| Hypoglycaemia | 5 | 2 |
| Cellulitis | 4 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Postgastrectomy Syndromes? (12)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Development and Validation of a Symptom-Focused Quality of Life Questionnaire (KOQUSS-40) for Gastric Cancer Patients after Gastrectomy. | Cancer research and treatment | 2021 | Yes |
| Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years. | International journal of clinical oncology | 2007 | Yes |
| Postoperative changes in body composition after gastrectomy. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract | 2005 | Yes |
| Postgastrectomy syndromes--diagnosis and treatment. | Best practice & research. Clinical gastroenterology | 2004 | Yes |
| Standard Roux-en-Y gastrojejunostomy vs. "uncut" Roux-en-Y gastrojejunostomy: a matched cohort study. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract | 2000 | Yes |
Showing 5 of 12 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.